Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / COM
-
Number of holders
-
196
-
Total shares
-
65.2M
-
Shares change
-
+1.13M
-
Total reported value, excl. options
-
$3.05B
-
Value change
-
+$63.4M
-
Put/Call ratio
-
0.36
-
Number of buys
-
101
-
Number of sells
-
-95
-
Price
-
$46.87
Significant Holders of IMPAX LABORATORIES INC - COM (IPXL) as of Q1 2015
201 filings reported holding IPXL - IMPAX LABORATORIES INC - COM as of Q1 2015.
IMPAX LABORATORIES INC - COM (IPXL) has 196 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65.2M shares
.
Largest 10 shareholders include ORBIMED ADVISORS LLC (6.68M shares), BlackRock Fund Advisors (5.31M shares), VANGUARD GROUP INC (4.8M shares), FRANKLIN RESOURCES INC (3.35M shares), Invesco Ltd. (3.33M shares), ARAVT GLOBAL LLC (2.67M shares), STATE STREET CORP (2.3M shares), Pennant Capital Management, LLC (2.03M shares), UBS GLOBAL ASSET MANAGEMENT AMERICAS INC (2.02M shares), and Slate Path Capital LP (1.94M shares).
This table shows the top 196 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.